References
- He XC, Zhang J, Tong WG, et al BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004;36:1117–1121.
- Zhang J, He XC, Tong WG, et al Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion. Stem Cells 2006;24:2826–2839.
- He XC, Yin T, Grindley JC, et al PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007;39:189–198.
- Swerdlow SH, Campo E, Harris NL, et al WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Geneva: WHO; 2008.
- Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–111.
- Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L. Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev 2005;19:1596–1611.
- Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 2001;153:1161–1174.
- Zhang J, Grindley JC, Yin T, et al PTEN maintains hematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006;441;518–522.
- Yilmaz OH, Valdez R, Theisen BK, et al PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006;441:475–482.